USD $0.00
Search more companies

Englewood Lab, Inc. (South Korea)

Main Activities: Other Chemical Product and Preparation Manufacturing | Cosmetics, Beauty Supplies, and Perfume Stores | Management of Companies and Enterprises
Secondary Activities: Toilet Preparation Manufacturing
Full name: Englewood Lab, Inc. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

The Company is a United States-based company engaged in the manufacture of cosmetic. The Company s products mainly consist of cream, serum, cleanser, eye cream and lipsticks under the brand such as Elizabeth Arden and Rodan Fields, L Oreal.
The Company s capabilities are:
Skincare manufacturing which includes a wide range of oils, creams, serums, cleansers, and masks for any application
Hybrid beauty products which comprise of multi-purpose makeup such as Primers foundations, BB CC cream (SPF), Concealer, Blush Illuminizers, Bronzer highlighter and Lip Care.
Providing certified facilities for producing over-the-counter (OTC) sunscreen and acne treatment products such as by the US Food and Drug Administration (FDA).
2004 Established Englewood LAB - Englewood Lab was established to deliver beauty innovation and best in class manufacturing on 2004.
2005 cGMP Certification - Englewood Lab received certification for Good Manufacturing Practice on 2005.
2011 Health Canada Registered - Expanding beyond beauty boundaries and borders Englewood Lab becomes Health Canada certified on 2011.
2014 TGA Registered (FDA Australia) - Englewood Lab becomes a global beauty force and receives Australia's TGA registration On 2014.
2015 Englewood LAB Korea was established on August 20, 2015 - Meeting industry trends and consumer needs, Englewood Lab opens a new innovation center in Korea on 2015.
2016 The Company s share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on October 14, 2016.
2017 Englewood LAB Totowa Factory Acquisition Totowa opens to accommodate Englewood Lab's rapid growth on 2017
2018 Acquired by Cosmecca Korea - Collaborated with Cosmecca Korea to increase synergy and strengthen competitiveness in the global market. On 8 June 2018, Cosmecca Korea Co Ltd, a listed entity in Korea Exchange became its largest shareholder.
2019 The Company started producing OTC products - Authorized to manufacture OTC products from USA FDA (classification: VAI). Englewood Lab Korea Cosmecca Korea R D Integration - Securing R D synergy to provide high-quality products to clients.
2020 New Expanded Batching Operation Commissioned In Totowa Facility - 88 Sheffield Facility De-commissioned.
2021 Completion of Micro Drug Stability Detps- Constantly enhancing the quality of our services/products through in-house micro lab.
2022 Solar Panel Installation

20 Campus Rd Totowa, Nj 07512, Usa
Jersey City; New Jersey;

Contact Details: Purchase the Englewood Lab, Inc. report to view the information.


Basic Information
Total Employees:
Purchase the Englewood Lab, Inc. report to view the information.
Outstanding Shares:
Purchase the Englewood Lab, Inc. report to view the information.
Registered Capital:
Purchase the Englewood Lab, Inc. report to view the information.
Financial Auditors:
Purchase the Englewood Lab, Inc. report to view the information.
Incorporation Date:
August 20, 2015
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
English Wood Lab Korea Co., Ltd
Company Performance
Financial values in the chart are available after Englewood Lab, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
Total operating revenue
Operating profit (EBIT)
Net Profit (Loss) for the Period
Total assets
Total equity
Operating Profit Margin (ROS)
Net Profit Margin
Return on Equity (ROE)
Debt to Equity Ratio
Quick Ratio
Cash Ratio

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?